Company intelligence / Profile preview

Emerginnova

Ownership: Private
Development stage: Commercial

Overview

Emerginnova distributes clinically proven dental wellness solutions in the U.S., focusing on metal-free ceramic dental implants and biological dental equipment. Their flagship product line includes ZERAMEX ceramic implant systems, which are FDA-cleared for use as a metal-free alternative to titanium implants. The company also offers biologic solutions such as PRF kits for periodontal regeneration. Clinical results reported by practitioners highlight high patient satisfaction with esthetic outcomes and biocompatibility[1][2][3][4].

Therapeutic areas: Other
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Partnerships

ZERAMEX (official North American distribution partnership)Anthogyr (historical distribution relationship via founder)

Beyond the preview

Go deeper on Emerginnova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerginnova.

Explore the full profile